Jefferies Group’s Agilon Health AGL Stock Holding History
Bought
Maintained
Sold
Other funds holding AGL
CDR
RSCM
Jefferies Group's AGL Position: Q1 2022 in Review
Jefferies Group sold out of Agilon Health (AGL) in Q1 2022, closing a stake of 566 shares — an estimated $382K sold.
Jefferies Group first reported a position in AGL in Q2 2021 and held it in 3 quarters. The position peaked at $382K in Q4 2021. 121 funds tracked by Wall St. Rank hold AGL as of Q1 2022.
- Jefferies Group reported no remaining Agilon Health position as of Q1 2022 after selling out during the quarter.
- Jefferies Group sold 566 Agilon Health shares in Q1 2022, an estimated $382K.
- Jefferies Group first reported a position in Agilon Health in Q2 2021 and held it in 3 quarters.
- Jefferies Group's Agilon Health position peaked at $382K in Q4 2021.
- 121 funds tracked by Wall St. Rank held Agilon Health as of Q1 2022.
Based on Jefferies Group's 13F filing for Q1 2022, filed 16 May 2022.